Compare MEDP & FIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | FIG |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | 1886 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 15.2B |
| IPO Year | 2016 | N/A |
| Metric | MEDP | FIG |
|---|---|---|
| Price | $480.16 | $21.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $498.25 | $50.50 |
| AVG Volume (30 Days) | 257.9K | ★ 10.7M |
| Earning Date | 04-22-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.98 | N/A |
| EPS | ★ 15.28 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.15 | $31.18 |
| Revenue Next Year | $7.47 | $20.22 |
| P/E Ratio | $30.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $250.05 | $19.82 |
| 52 Week High | $628.92 | $114.29 |
| Indicator | MEDP | FIG |
|---|---|---|
| Relative Strength Index (RSI) | 55.95 | 37.80 |
| Support Level | $452.55 | $19.85 |
| Resistance Level | $501.30 | $25.17 |
| Average True Range (ATR) | 16.15 | 1.54 |
| MACD | 4.20 | -0.53 |
| Stochastic Oscillator | 97.26 | 18.09 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Figma Inc is engaged in transforming ideas into digital products and experiences. The group focuses on the entire software creation lifecycle, enabling it to quickly launch new products on Figma's browser-based platform and reinforcing its belief that design extends well beyond a single step or role. The company adopts an expansive view, as design is more than how something looks, feels, or works. It derives its revenue from sales of subscriptions for access to its platform.